RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 27, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

June 30, 2026

Conditions
Mood DisordersAnxietyDepressive SymptomsDepressionAnxiety DisordersAnxiety Depression
Interventions
BEHAVIORAL

+RxWell

During the SuRxgWell trial, if a participant is randomized to receive RxWell, they will be provided with an access code that is required to download the app. Once the participant has downloaded the app, they will be paired with a UPMC coach who will guide the person through the sessions using in-app texting to help give them the tools needed to actively cope with anxiety and/or depression. The UPMC coaches are supervised by a licensed UPMC mental health clinician. The participant will have access to the app and coach for six months after they have consented. The digital behavioral tool includes over 30 brief Cognitive Behavioral Therapy (CBT) and mindfulness-based techniques.

BEHAVIORAL

-RxWell

Treatment as usual

Trial Locations (3)

15146

RECRUITING

UPMC East, Monroeville

15232

RECRUITING

UPMC Shadyside, Pittsburgh

15237

RECRUITING

UPMC Passavant, Pittsburgh

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pittsburgh

OTHER